Related Experiment Video
Updated: Feb 28, 2026

07:55
Pancreatic Tissue-Derived Extracellular Matrix Bioink for Printing 3D Cell-Laden Pancreatic Tissue Constructs
Published on: December 13, 2019
11.6K
Bioprinting of 3D Tissue Models Using Decellularized Extracellular Matrix Bioink
1Department of Biomedical Engineering, Indian Institute Technology Hyderabad, Kandi, Sangareddy, 502285, Telangana, India. falguni@iith.ac.in.
Methods in Molecular Biology (Clifton, N.J.)
|June 22, 2017
Summary
Researchers developed a novel bioink from decellularized extracellular matrices (dECMs) for bioprinting. This dECM bioink supports cell growth and function, creating complex 3D tissue structures for regenerative medicine applications.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Bioprinting enables the creation of three-dimensional (3D) tissue analogues by patterning cells and extracellular matrix (ECM) materials.
- Current bioinks often fail to replicate the natural ECM complexity, hindering cellular morphology and function reconstitution.
- Developing advanced bioinks is crucial for fabricating functional tissue constructs.
Purpose of the Study:
- To present a novel method for creating bioinks from decellularized extracellular matrices (dECMs).
- To establish a protocol for bioprinting cell-laden constructs using dECM bioink.
- To evaluate the potential of dECM bioink in supporting 3D tissue formation with high cell viability and functionality.
Main Methods:
- Decellularization of native tissues (adipose, cartilage, heart) to obtain ECM components.
- Processing of dECMs into a printable bioink formulation.
- Bioprinting of cell-laden constructs using the developed dECM bioink.
- Assessment of cell viability, morphology, and functionality within the 3D bioprinted constructs.
Main Results:
- Successful preparation of bioinks from various dECM sources.
- Demonstrated ability of dECM bioink to provide an optimized microenvironment for cell growth.
- Achieved high cell viability and functionality in the bioprinted tissue structures.
- Fabricated 3D structured tissues with improved cellular integration and function.
Conclusions:
- Decellularized ECMs represent a promising source for developing advanced bioinks.
- The novel dECM bioink facilitates the bioprinting of functional 3D tissue constructs.
- This approach holds potential for applications in tissue engineering and regenerative medicine.

